Skip to main content

Table 3 The primary outcomes for all patients in different subgroups

From: Risk factors for mortality in critically ill patients with COVID-19: a multicenter retrospective case-control study

Primary outcomes N(%) Total
(N = 304)
LYM>0.8
(N = 191)
LYM ≤ 0.8
(N = 113)
P value
28-day mortality 37 (12%) 10 (5%) 27 (24%) < 0.001
60-day mortality 49 (16%) 13 (7%) 36 (32%) < 0.001
  Total
(N = 311)
SOFA>3.0
(N = 78)
SOFA≤3.0
((N = 233)
P value
28-day mortality 36 (11%) 32 (41%) 4 (2%) < 0.001
60-day mortality 47 (15%) 41 (53%) 6 (3%) < 0.001
  Total
(N = 302)
APACHE II>7.0
(N = 102)
APACHEII≤7.0
(N = 200)
P value
28-day mortality 36 (12%) 32 (31%) 4 (2%) < 0.001
60-day mortality 47 (16%) 42 (41%) 5 (3%) < 0.001
  Total
(N = 215)
Pa02/FiO2>200
(N = 140)
Pa02/FiO2 ≤ 200
(N = 75)
P value
28-day mortality 31 (14%) 11 (8%) 20 (27%) < 0.001
60-day mortality 42 (20%) 13 (9%) 29 (39%) < 0.001
  Total
(N = 186)
IL-6>120
(N = 11)
IL-6 ≤ 120
(N = 175)
P value
28-day mortality 20 (11%) 4 (36%) 16 (9%) 0.020
60-day mortality 27 (15%) 6 (55%) 21 (12%) 0.002
  Total
(N = 296)
CRP>52
(N = 81)
CRP ≤ 52
(N = 215)
P value
28-day mortality 34 (12%) 20 (25%) 14 (7%) < 0.001
60-day mortality 46 (16%) 28 (35%) 18 (8%) < 0.001
  Total
(N = 325)
Critical type
(N = 103)
Severe type
(N = 222)
P value
28-day mortality 42 (13%) 36 (35%) 6 (3%) < 0.001
60-day mortality 55 (17%) 49 (48%) 6 (3%) < 0.001